Kalbasi, Anusha http://orcid.org/0000-0001-8692-1457
Ribas, Antoni http://orcid.org/0000-0003-3669-8458
Article History
Accepted: 15 August 2019
First Online: 30 September 2019
Competing interests
: A.K. has no competing financial or other conflicts of interest. A.R. has received honoraria from consulting with Amgen, Bristol-Myers Squibb, Chugai, Genentech, Merck, Novartis and Roche and is or has been a member of the scientific advisory board and holds stock in Advaxis, Arcus Biosciences, Bioncotech Therapeutics, Compugen, CytomX, Five Prime, FLX-Bio, ImaginAb, Isoplexis, Kite-Gilead, Lutris Pharma, Merus, PACT Pharma, Rgenix and Tango Therapeutics.